Keenova's Xiaflex meets primary endpoint in plantar fibromatosis trial

July 8, 2026 7:00 AM

Keenova Therapeutics plc announced positive results from its Phase 3 clinical trial of XIAFLEX (collagenase clostridium histolyticum) for the treatment ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found